Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep861 | Reproductive and Developmental Endocrinology | ECE2022

Associations of serum AMH levels and hormonal, metabolic and cardiovascular parameters in adult men

Tandl Veronika , Colantonio Caterina , Haudum Christoph W , Hutz Barbara , Kolesnik Ewald , Schmidt Albrecht , Zirlik Andreas , Verheyen Nicolas , Pieber Thomas R , Obermayer-Pietsch Barbara

Background: Anti-Müllerian hormone (AMH) is well known for its association with ovarian follicular count and ovarian reserve in general as well as for its recruitment of primordial follicles in women. With an explicit decrease in menopause, it is mainly used for clinical questions from in-vitro-fertilisation to polycystic ovary syndrome. Interestingly, AMH levels in men are quite high during lifetime, but there is only few data about its relevance and potential effects in...

ea0090p175 | Reproductive and Developmental Endocrinology | ECE2023

Women with preeclampsia show altered cortico- and sex steroid profiles

Trummer Olivia , Stern Christina , Reintar Sharmaine , Tandl Veronika , Mayer-Pickel Karoline , Cervar-Zivkovic Mila , Fassnacht Martin , Kurlbaum Max , Huppertz Berthold , Fluhr Herbert , Obermayer-Pietsch Barbara

Background: Preeclampsia (PE) is a complex condition of pregnancy, associated with substantial perinatal morbidity and mortality, affecting 2% to 8% of pregnancies worldwide. Its hallmarks are high blood pressure (hypertension) and endothelial dysfunction, leading to potential end-organ injury. Affected organ systems include liver, blood, kidneys, brain and placenta. In the present study, we investigated steroid hormones such as progestagens, estrogens, androgens, and glucocor...

ea0090p545 | Late-Breaking | ECE2023

AMH in men: Higher serum levels associated with healthy male aging

Tandl Veronika , Haudum Christoph W. , Eberhard Katharina , Hutz Barbara , Kolesnik Ewald , Schmidt Albrecht , Zirlik Andreas , von Lewinski Dirk , Scherr Daniel , Verheyen Nicolas , Pieber Thomas R. , Obermayer-Pietsch Barbara

Anti-Müllerian hormone (AMH), known for its role in fetal development and female reproduction, is also present in adult and elderly men in considerable amounts. In recent years, controversial findings regarding relations to age, other hormones, and BMI (possibly based on a dilutional effect due to higher blood volume) have been discussed. To date, little is known of its clinical relevance in this population. We aimed to further investigate AMH levels in an aging male popu...

ea0093oc35 | Oral communication 5: Reproductive Endocrinology | EYES2023

Alteration of adrenal and sex steroid profiles in pregnant women with preeclampsia

Trummer Olivia , Stern Christina , Reintar Sharmaine , Tandl Veronika , Mayer-Pickel Karoline , Cervar-Zivkovic Mila , Fassnacht Martin , Kurlbaum Max , Huppertz Berthold , Fluhr Herbert , Obermayer-Pietsch Barbara

Background: Preeclampsia (PE) is a serious and complex pregnancy-related condition, characterized by hypertension and endothelial dysfunction, which can potentially damage liver, brain and kidneys, resulting to an increased perinatal morbidity and mortality. We investigated pregnancy-related steroid hormones such as progestogens, estrogens, androgens, and glucocorticoids to assess maternal and fetal development. We aim to compare steroid hormone profiles throughout pregnancy, ...

ea0093oc38 | Oral communication 5: Reproductive Endocrinology | EYES2023

Body composition in association with serum anti-Müllerian hormone (AMH) levels in adult males implies hemodilution effects

Tandl Veronika , Haudum Christoph , Eberhard Katharina , Hutz Barbara , Foessl Ines , Kolesnik Ewald , Zirlik Andreas , von Lewinski Dirk , Scherr Daniel , Verheyen Nicolas , Pieber Thomas , Obermayer-Pietsch Barbara

Background: A negative relationship between body mass index (BMI) and serum Anti-Müllerian hormone (AMH) levels has been previously reported. Whether this is because of an adverse effect of adiposity on AMH production or the hormone’s dilution in a higher blood volume that accompanies larger body size (‘hemodilution’) is not yet clear. Blood volume can be estimated by body weight, body surface area (BSA) or lean mass (LM). Of note, adipose tissue is poorly ...

ea0090p77 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

En route to sarcopenia biomarkers: dp-ucMGP in relation to muscle mass and function

Tandl Veronika , Schweighofer Natascha , Trummer Olivia , Haudum Christoph W. , Lind Alice F. , Kolesnik Ewald , Mursic Ines , Scherr Daniel , Zirlik Andreas , Pieber Thomas R. , Verheyen Nicolas D. , Obermayer-Pietsch Barbara

Sarcopenia is characterized by progressive loss of both mass and function of skeletal muscle when ageing. It poses a serious issue for healthcare systems, as it is associated with increased risk of falls, osteoporosis, and mortality. To date, no ideal serum biomarkers for the diagnosis of this complex condition have been identified. Matrix-GLA-protein (MGP), primarily known as a vitamin K dependent calcification inhibitor, is present and active in bone, muscle, and adipose tis...

ea0090oc11.2 | Oral Communications 11: Late Breaking | ECE2023

Machine learning-based steroid metabolome analysis reveals three distinct subtypes of polycystic ovary syndrome and implicates 11-oxygenated androgens as major drivers of metabolic risk

Melson Eka , Rocha Thais P. , Veen Roland J. , Abdi Lida , Mcdonnell Tara , Tandl Veronika , Hawley James M. , Wittemans Laura B.L. , Anthony Amarah V. , Gilligan Lorna C. , Shaheen Fozia , Kempegowda Punith , Gillett Caroline D.T , Cussen Leanne , Missbrenner Cornelia , Lajeunesse-Trempe Fannie , Gleeson Helena , Aled Rees D. , Robinson Lynne , Jayasena Channa , Randeva Harpal S. , Dimitriadis Georgios K. , Gomes Larissa , Sitch Alice J. , Vradi Eleni , Taylor Angela E. , O'Reilly Michael W. , Obermayer-Pietsch Barbara , Biehl Michael , Arlt Wiebke

Introduction: Polycystic ovary syndrome affects 10% of women and comes with a 2-3fold increased risk of type 2 diabetes, hypertension, and fatty liver disease. Androgen excess, a cardinal feature of PCOS, has been implicated as a major contributor to metabolic risk. Adrenal-derived 11-oxygenated androgens represent an important component of PCOS-related androgen excess and are preferentially activated in adipose tissue. We aimed to identify PCOS sub-types with distinct androge...

ea0094oc4.1 | Reproductive Endocrinology | SFEBES2023

Unsupervised steroid metabolome cluster analysis to dissect androgen excess and metabolic dysfunction in 488 women with polycystic ovary syndrome – results from the prospective DAISy-PCOS study

Melson Eka , Rocha Thais P. , Veen Roland J. , Abdi Lida , McDonnell Tara , Tandl Veronika , Hawley James M. , Wittemans Laura B. L. , Anthony Amarah V. , Gilligan Lorna C. , Shaheen Fozia , Kempegowda Punith , Gillett Caroline D.T. , Cussen Leanne , Missbrenner Cornelia , Lajeunesse-Trempe Fannie , Gleeson Helena , Rees Aled , Robinson Lynne , Jayasena Channa , Randeva Harpal S. , Dimitriadis Georgios K. , Gomes Larissa G. , J. Sitch Alice , Vradi Eleni , Obermayer-Pietsch Barbara , O'Reilly Michael W. , Taylor Angela E. , Biehl Michael , Arlt Wiebke

Introduction: Polycystic ovary syndrome (PCOS) affects 10% of women and is associated with a 2-3fold risk of type 2 diabetes (T2D), hypertension, fatty liver and cardiovascular disease. Androgen excess has been implicated as a major contributor to metabolic risk in PCOS. We aimed to identify PCOS sub-types with distinct androgen profiles and compare their cardiometabolic risk.Methods: We cross-sectionally studied 488 tre...